JGC
COVS

J. Goldman & Co’s Covisint Corporation COVS Stock Holding History

J. Goldman & Co’s Portfolio COVS Stock Details COVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,042,021
Closed -$2.55M – 457
2017
Q2 		$2.55M Sell
1,042,021
-2,335,725
-69% -$4.88M 0.14% 159
2017
Q1 		$6.92M Hold
3,377,746
– – 0.34% 97
2016
Q4 		$6.42M Sell
3,377,746
-3,463
-0.1% -$7.47K 0.42% 73
2016
Q3 		$7.37M Hold
3,381,209
– – 0.42% 69
2016
Q2 		$7.37M Buy
3,381,209
+60,400
+2% +$117K 0.38% 60
2016
Q1 		$6.64M Buy
3,320,809
+434,376
+15% +$881K 0.41% 70
2015
Q4 		$7.22M Buy
2,886,433
+316,138
+12% +$716K 0.74% 39
2015
Q3 		$5.53M Sell
2,570,295
-25,665
-1% -$70.6K 0.47% 68
2015
Q2 		$8.49M Buy
2,595,960
+1,517,541
+141% +$3.6M 0.52% 56
2015
Q1 		$2.19M Buy
1,078,419
+40,929
+4% +$95.4K 0.14% 177
2014
Q4 		$2.75M Buy
1,037,490
+823,427
+385% +$2.36M 0.33% 94
2014
Q3 		$888K Buy
+214,063
New +$961K 0.05% 225

J. Goldman & Co's COVS Position: Q3 2017 in Review

J. Goldman & Co sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 1,042,021 shares — an estimated $2.55M sold.

J. Goldman & Co first reported a position in COVS in Q3 2014 and held it in 12 quarters. The position peaked at $8.49M in Q2 2015. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

  • J. Goldman & Co reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
  • J. Goldman & Co sold 1,042,021 Covisint Corporation shares in Q3 2017, an estimated $2.55M.
  • J. Goldman & Co first reported a position in Covisint Corporation in Q3 2014 and held it in 12 quarters.
  • J. Goldman & Co's Covisint Corporation position peaked at $8.49M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on J. Goldman & Co's 13F filing for Q3 2017, filed 14 Nov 2017.